our storysupportareasstartlatest
previoustalkspostsconnect

Achilles Therapeutics Transfers Technology Assets to AstraZeneca

December 25, 2024 - 05:18

Achilles Therapeutics Transfers Technology Assets to AstraZeneca

Achilles Therapeutics has officially transferred its proprietary data and samples from the TRACERx study and the Material Acquisition Platform (MAP) to AstraZeneca. This significant transaction marks the conclusion of a strategic review aimed at optimizing the company’s focus on its core therapeutic development initiatives.

The TRACERx study, which investigates the evolution of non-small cell lung cancer (NSCLC), has generated valuable insights into cancer progression and treatment responses. By transferring these assets to AstraZeneca, Achilles Therapeutics aims to leverage AstraZeneca's extensive resources and expertise in oncology to further advance research and development in this critical area of cancer treatment.

This move not only strengthens the collaboration between the two companies but also enhances the potential for innovative therapeutic solutions in the fight against NSCLC. As the landscape of cancer research evolves, partnerships like this one are crucial for accelerating the development of effective treatments that can significantly improve patient outcomes.


MORE NEWS

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

August 2, 2026 - 00:47

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The Food and Drug Administration is nearing a decision on a new type of influenza vaccine developed by Moderna, one that uses the same messenger RNA platform behind the company`s COVID-19 shots. If...

Stevens Institute of Technology chooses Englot as interim dean for its School of Computing

August 1, 2026 - 02:37

Stevens Institute of Technology chooses Englot as interim dean for its School of Computing

Stevens Institute of Technology has named Brendan Englot as the interim dean for its School of Computing, with the appointment taking effect on August 1. Englot, who currently serves as a professor...

Montage Technology Announces Industry-First Trial Production of CXL 3.2 MXC Chip

July 31, 2026 - 09:35

Montage Technology Announces Industry-First Trial Production of CXL 3.2 MXC Chip

Montage Technology has reached a new milestone by moving its CXL 3.2 Memory eXpander Controller, or MXC, into trial production. The company says this is the first time such a chip has reached this...

Silent Hill: Townfall Developers discuss the Scottish setting, retro technology, first-person combat

July 30, 2026 - 23:47

Silent Hill: Townfall Developers discuss the Scottish setting, retro technology, first-person combat

The upcoming `Silent Hill: Townfall` is shaping up to be a radical departure for the series, and not just because of its shift to first-person combat. In a recent interview, the development team...

read all news
our storysupportareasstartrecommendations

Copyright © 2026 Bitetry.com

Founded by: Vincent Hubbard

latestprevioustalkspostsconnect
privacyuser agreementcookie settings